April 2012 | Donate
Valproic Acid Clinical Trial for RP Expanding to Boost Participant Enrollment
The Foundation-funded study, which began last year, is for the treatment of autosomal dominant retinitis pigmentosa.
Usher Syndrome Gene Therapy Study Begins in Oregon
Oxford BioMedica, a Foundation partner and developer of two other treatments for retinal diseases, will soon treat patients who have both vision and hearing loss.
Foundation Commits $2 Million to Development of
a Cross-Cutting Drug Treatment
The start-up company MitoChem Therapeutics has identified three compounds
that could benefit people affected by a variety of retinal diseases.
Eye on the Cure: Reporting from Israel
wrap-up of the blog posts submitted by Dr. Steve Rose, the Foundation’s chief
research officer, during and after his trip to the Middle East.
EYE ON THE CURE BLOG
Optogenetics: Seeing the Light in a Whole New Way
A gene therapy technique that bypasses rods and cones.
The Importance of Stem Cells
Guest blogger Dr. David Gamm reports on the impact that stem
cell research is making in the fight against blindness.
STORIES OF HOPE
His Mother’s Son
Of the many things Eric Fulton has learned from his mother, Fran, her example of how to live independently in spite of failing vision from RP may be her best lesson.
The Jenkins family isn’t letting X-linked RP, which affects 8-year-old Aidan, hold them back. They’re focused on what matters most: raising money for research and making memories.
A smorgasbord of
themes and a hefty helping of funds served as highlights of the Foundation’s
dinner events during the first quarter of 2012.
Visit our Web site for a complete list of Foundation events nationwide.
Check us out on: